Related Experiment Videos
CFTR gene mutations and male infertility
1Institut für Humangenetik, Medizinischen Hochschule, Hannover, Germany. Stuhrmann.Manfred@MH-Hannover.de
Andrologia
|February 7, 2001
Summary
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene frequently cause male infertility via obstructive azoospermia. Genetic testing for CFTR mutations is recommended for men with this condition to assess risks for cystic fibrosis offspring.
Area of Science:
- Genetics
- Reproductive Medicine
- Medical Science
Background:
- Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are a common genetic cause of male infertility.
- CFTR gene mutations can lead to typical cystic fibrosis (CF) or atypical, often monosymptomatic, forms affecting the male reproductive system.
Purpose of the Study:
- To highlight the link between CFTR gene mutations and male infertility, specifically obstructive azoospermia.
- To emphasize the importance of genetic counseling and CFTR gene analysis for affected individuals and couples.
Main Methods:
- Review of the molecular consequences of CFTR mutations.
- Analysis of clinical presentations of CFTR-related male infertility, including congenital absence of the vas deferens and ejaculatory duct obstruction.
Main Results:
- CFTR mutations are a frequent cause of obstructive azoospermia, a form of male infertility.
- Males with idiopathic obstructive azoospermia have an increased risk of carrying CFTR mutations and fathering offspring with cystic fibrosis.
Conclusions:
- Genetic counseling and molecular genetic analysis of the CFTR gene are crucial for couples undergoing assisted reproductive technologies for obstructive azoospermia.
- Identifying CFTR mutations in infertile males is essential for reproductive planning and assessing the risk of cystic fibrosis in offspring.